The same in ovarian cancer cells where the inhibition of Shp1 activity reduces tumor growth by increasing intracellular levels of the Cdk2/p27(kip1) and Cdk2/Shp1 complexes (26). The gene discussed is CDK2; the disease is ovarian cancer.